Clinical Trial Update: Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, tolerability, and pharmacokinetics data for crisaborole (AN2728) in adolescents with atopic dermatitis. The Phase 1/2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-24